Financhill
Back

Robert Half Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
57

RHI
Robert Half

Last Price:
66.80
Seasonality Move:
5.45%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
57
Robert Half (RHI) is a Buy

Is Robert Half a Buy, Sell or Hold?

  • The current Robert Half [RHI] share price is $66.80. The Score for RHI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • RHI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RHI Stock Price Chart

What is Robert Half's stock price today?

  • The Robert Half share price today is $66.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RHI is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RHI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.7 Buy
Relative Strength Index (14 RSI): 68.24 Buy
Chaikin Money Flow: 7362411 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.34 - 64.22) Buy
Bollinger Bands (100): (61.42 - 67.48) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

RHI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.86 Buy
20-day SMA: 63.05 Buy
50-day SMA: 62.91 Buy
200-day SMA: 72.15 Sell
8-day EMA: 64.36 Buy
20-day EMA: 63.28 Buy
50-day EMA: 63.31 Buy
200-day EMA: 69.05 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Robert Half Earnings Growth & RHI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.23 per share, a decrease this year of $1.32 per share, and an increase next year of $0.75 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Robert Half Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):